BIOTECanada, the national industry association representing Canada’s biotechnology and life sciences sector, has praised the 2025 Federal Budget for delivering “breakthrough wins” that strengthen the country’s innovation ecosystem and economic resilience.
In a statement released via Business Wire, BIOTECanada said the budget’s measures will accelerate investment, research, and regulatory modernization—helping Canada position itself as a global leader in biotechnology and a key driver of sustainable growth.
Key Announcements and Investments
The federal budget identifies life sciences as a strategic national sector, prioritizing it under major innovation and financing programs, including:
A $1-billion Venture Capital Catalyst Initiative (VCCI) with a dedicated directive for life sciences investment.
The expansion of SR&ED (Scientific Research and Experimental Development) eligibility to support early-stage R&D.
A more competitive intellectual property (IP) regime to protect and scale Canadian innovations.
Dual-use technology commitments, supporting advancements that serve both civilian and defence applications.
“The government clearly recognizes life sciences as a strategic driver of Canada’s economy,” said Wendy Zatylny, President and CEO of BIOTECanada.
“These measures strengthen the full innovation continuum—from early-stage research to scale-up investment—helping companies grow in Canada, attract global capital, and anchor more of the value chain at home.”
Sector Significance
Canada’s life sciences industry employs thousands of skilled professionals, drives innovation in health, environment, and food security, and attracts significant foreign direct investment.
Globally, countries are increasingly treating biotechnology as a pillar of economic and national security. Canada’s investments position it to capitalize on this momentum, fostering a robust foundation for future growth.
BIOTECanada noted that continued collaboration between government and industry will be essential to translate these policy commitments into long-term competitiveness and sustainable economic impact.
About BIOTECanada
BIOTECanada represents over 200 member organizations spanning pre-commercial biotech startups, global pharmaceutical firms, venture investors, accelerators, and academic institutions.
The association advocates for biotechnology as a critical tool in addressing human health, food sustainability, and climate challenges — areas increasingly central to Canada’s global leadership goals.
“A strong life sciences sector depends on consistent, connected policy—from SR&ED research to venture capital support. The 2025 budget helps complete that continuum,” Zatylny added.
For more information, visit www.biotech.ca.
(Source: Business Wire)
